CompletedNCT01234454
Three Antipsychotics and Brain Function in Schizophrenia
About this title
Read the official source — NCT01234454Medication studyAges 18–60United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- Chapel HillSee all locations and recruitment
Study information
Study start dateJanuary 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 34
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT01234454
- Official title
Show the full official title
Risperidone Effects On Frontal And Temporal Cortical Function In Schizophrenia Patients Undergoing FMRI Cognitive Task Performance
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chapel Hill
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of North Carolina, Chapel Hill, a university.
Did this study involve medication?
Yes. The study involved medication, including Risperidone and Olanzapine.
Who was this study for?
Listed age limits: 18 years to 60 years.
Want to explore more studies?
Explore studiesRelated studies
Paliperidone Injections Compared With Oral Medication for Schizophrenia
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia